WALLDORF — SAP SE (NYSE: SAP) is announcing a smart app designed to track, trace and authenticate prescription medicines in the United States. Developed in partnership with leading global pharmaceutical research company Boehringer Ingelheim , the smart app will enable law enforcement officials to potentially detect illicit, counterfeit or unapproved Boehringer Ingelheim medicines being smuggled into the United States or sold illegally.
↧